Search Results - "CASINELLO, J"

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced metastatic breast cancer by BATISTA, N, PEREZ-MANGA, G, CASINELLO, J, REGUEIRO, P, MURIAS, A, CONSTENLA, M, RUIZ, A, CARABANTES, F, CASTELLANOS, J, GONZALEZ BARON, M, VILLMAN, K, SÖDERBERG, M, AHLGREN, J

“…The addition of oral capecitabine to docetaxel improves response rate, time to progression (TTP) and overall survival in anthracycline-pretreated metastatic…”
Get full text

689 RESEARCH STUDY ON THE HEALTH OUTCOMES OF CANCER PAIN TREATMENT USING TRANSDERMAL BUPRENORPHINE by Camps, C, Casinello, J, Virizuela, J.A, Escobar, Y, Alberola, V, Carulla, J, Sánchez-Magro, I

Get full text

Experience with sunitinib in hormone-resistant metastatic prostate cancer that is unresponsive to docetaxel by Gasent, J.M, Grande, E, Casinello, J, Provencio, M, Laforga, J.B, Alberola, V

“…Abstract Introduction Systemic treatment options for patients with hormone-refractory prostate cancer (HRPC) that progress despite the use of Docetaxel are…”
Get full text

7037 Clinical, biochemical (PSA) and radiographic benefit with sunitinib as a single agent in metastatic chemoresistant and hormone-refractory prostate cancer (HRPC) patients by Castellano, D, Larriba, J. Gonzalez, Aparicio, L.M. Antón, Casinello, J, Grande, E, Esteban, E, Sepulveda, J, Rodriguez, A, Cañete, I. Ghanem

Get full text

Co-existent ovarian mucinous cystadenocarcinoma and ovarian choriocarcinoma by Jiménez-Heffernan, J A, Perna, C, Martínez, A, Casinello, J, Cuevas, J

“…We present the case of a 63-year-old woman with an ovarian neoplasm in which mucinous cystadenocarcinoma and choriocarcinoma coexisted. Blood levels of…”
Get full text

Experiencia con sunitinib en cáncer de próstata metastásico hormonorresistente sin respuesta a docetaxel by Gasent, J.M, Grande, E, Casinello, J, Provencio, M, Laforga, J.B, Alberola, V

“…Resumen Introducción las opciones de tratamiento sistémico para los pacientes con cáncer de próstata hormonorrefractario (CPHR) que progresan a pesar del uso…”
Get full text

Prognostic Factors Influencing the Selection of Bevacizumab Combined With Chemotherapy in Patients With HER2-Negative Metastatic Breast Cancer in Routine Clinical Practice. Oncosur-Avalox: Observational Cross-Sectional Study by Manso, L., Perez-Carrion, R., Chacon Lopez-Muniz, J.I., García Palomo, A., Galve Calvo, E., Llorente, R.M., Casinello, J., Catalán, G., Llorca, C., Grávalos, C.

Get full text

Experiencia con sunitinib en cáncer de próstata metastásico hormonorresistente sin respuesta a docetaxel by Gasent, J.M., Grande, E., Casinello, J., Provencio, M., Laforga, J.B., Alberola, V.

Get full text

Experience with sunitinib in hormone-resistant metastatic prostate cancer that is unresponsive to docetaxel by Gasent, J M, Grande, E, Casinello, J, Provencia, M, Laforga, J B, Alberola, V

“…INTRODUCTIONsystemic treatment options for patients with hormone-refractory prostate cancer (HRPC) that progress despite the use of Docetaxel are very limited…”
Get full text

The human dimension that favours the unnatural expansion of an exotic ungulate (Ammotragus lervia) throughout the Iberian Peninsula by Serrano, E., Calabuig, G., Casinello, J., Pérez, J. M.

Get full text

The human dimension that favours the unnatural expansion of an exotic ungulate (Ammotragus lervia) throughout the Iberian Peninsula by E. Serrano, G. Calabuig, J. Casinello, J. M. Pérez

“…[fr] La présence de l'aoudad, Ammotragus lervia, dans la Péninsule ibérique a été notée tant en populations en liberté qu'en réserves de chasse. Il a été…”
Get full text